Michele Maio

Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers?

A. Covre, Z. M. Besharat, A. D. Di Giacomo, 2024, Pharmacology & therapeutics.

Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream

A. Delmonte, G. Bronte, A. Covre, 2024, Frontiers in immunology.

The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role?

B. Fox, A. M. Giacomo, M. Lahn, 2023, European journal of cancer.

Immunotherapy in cutaneous melanoma and biologics in psoriatic disease: similarities and differences from a clinical multidisciplinary perspective

P. Malagoli, A. D. Di Giacomo, G. Roccuzzo, 2024, Expert opinion on biological therapy.

Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches

T. Noviello, A. Anichini, R. Mortarini, 2024, Journal of translational medicine.